Author

Dominique Lamarque

14-DAY TAILORED PCR-GUIDED TRIPLE THERAPY VERSUS 14-DAY NON-BISMUTH CONCOMITANT QUADRUPLE THERAPY FOR HELICOBACTER PYLORI ERADICATION: A MULTICENTER, OPEN-LABEL RANDOMIZED CONTROLLED TRIAL, THE HEPYSE TRIAL
14-DAY TAILORED PCR-GUIDED TRIPLE THERAPY VERSUS 14-DAY NON-BISMUTH CONCOMITANT QUADRUPLE THERAPY FOR HELICOBACTER PYLORI ERADICATION: A MULTICENTER, OPEN-LABEL RANDOMIZED CONTROLLED TRIAL, THE HEPYSE TRIAL

Dominique Lamarque  et al.

DEVELOPMENT OF AN ORIGINAL AUTOMATED METHOD OF THREE-DIMENSIONAL RECONSTRUCTION OF AN EXTENDED FIELD OF VIEW OF THE GASTRIC ANTRUM
DEVELOPMENT OF AN ORIGINAL AUTOMATED METHOD OF THREE-DIMENSIONAL RECONSTRUCTION OF AN EXTENDED FIELD OF VIEW OF THE GASTRIC ANTRUM

Dominique Lamarque  et al.

SERUM PEPSINOGENS COMBINED WITH NEW BIOMARKERS MEASURED BY CHEMILUMINESCENT ENZYME IMMUNOASSAY FOR NON-INVASIVE DIAGNOSIS OF ATROPHIC GASTRITIS: A PROSPECTIVE MULTICENTER STUDY
SERUM PEPSINOGENS COMBINED WITH NEW BIOMARKERS MEASURED BY CHEMILUMINESCENT ENZYME IMMUNOASSAY FOR NON-INVASIVE DIAGNOSIS OF ATROPHIC GASTRITIS: A PROSPECTIVE MULTICENTER STUDY

Dominique Lamarque  et al.

SERUM PEPSINOGEN LEVELS IN PATIENTS WITH DIFFERENT TYPES OF ATROPHIC GASTRITIS MEASURED BY ELISA AND CHEMILUMINESCENT IMMUNOASSAY
SERUM PEPSINOGEN LEVELS IN PATIENTS WITH DIFFERENT TYPES OF ATROPHIC GASTRITIS MEASURED BY ELISA AND CHEMILUMINESCENT IMMUNOASSAY

Dominique Lamarque  et al.

KILLING TWO BIRDS WITH ONE STONE: THE FIRST MULTISYSTEM-COMPATIBLE, ARTIFICIAL INTELLIGENCE SOLUTION FOR SMALL-BOWEL CAPSULE ENDOSCOPY
KILLING TWO BIRDS WITH ONE STONE: THE FIRST MULTISYSTEM-COMPATIBLE, ARTIFICIAL INTELLIGENCE SOLUTION FOR SMALL-BOWEL CAPSULE ENDOSCOPY

Dominique Lamarque  et al.

ANTIBIOTIC RESISTANCE TRENDS OF HELICOBACTER PYLORI NAÏVE PATIENTS IN THE PERIOD 2013-2020: ANALYSIS OF THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
ANTIBIOTIC RESISTANCE TRENDS OF HELICOBACTER PYLORI NAÏVE PATIENTS IN THE PERIOD 2013-2020: ANALYSIS OF THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Dominique Lamarque  et al.

EXPERIENCE WITH RIFABUTIN-CONTAINING THERAPY IN 426 PATIENTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
EXPERIENCE WITH RIFABUTIN-CONTAINING THERAPY IN 426 PATIENTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Dominique Lamarque  et al.

EMPIRICAL SECOND-LINE TREATMENTS IN EUROPE: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
EMPIRICAL SECOND-LINE TREATMENTS IN EUROPE: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Dominique Lamarque  et al.

EXPERIENCE WITH SINGLE-CAPSULE BISMUTH QUADRUPLE THERAPY IN 6,000 PATIENTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
EXPERIENCE WITH SINGLE-CAPSULE BISMUTH QUADRUPLE THERAPY IN 6,000 PATIENTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Dominique Lamarque  et al.

EMPIRICAL FIRST-LINE TREATMENT USE AND EFFECTIVENESS TRENDS IN EUROPE IN THE PERIOD 2013-2020: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
EMPIRICAL FIRST-LINE TREATMENT USE AND EFFECTIVENESS TRENDS IN EUROPE IN THE PERIOD 2013-2020: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Dominique Lamarque  et al.

FIRST-LINE EMPIRICAL H. PYLORI ERADICATION THERAPY IN EUROPE: RESULTS FROM 30,000 CASES OF THE EUROPEAN REGISTRY ON H. PYLORIMANAGEMENT (HP-EUREG)
FIRST-LINE EMPIRICAL H. PYLORI ERADICATION THERAPY IN EUROPE: RESULTS FROM 30,000 CASES OF THE EUROPEAN REGISTRY ON H. PYLORIMANAGEMENT (HP-EUREG)

Dominique Lamarque  et al.

EXPERIENCE WITH SINGLE CAPSULE BISMUTH QUADRUPLE THERAPY IN 5,000 PATIENTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
EXPERIENCE WITH SINGLE CAPSULE BISMUTH QUADRUPLE THERAPY IN 5,000 PATIENTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Dominique Lamarque  et al.

Item 1 - 12 / 12
1